Hepatic Impairment: Clinical Trials

2 trials for Hepatic Impairment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1
Phase 11Unknown 1

Follow Hepatic Impairment: new trials by email Literature Review of Hepatic Impairment trials Research Report on Hepatic Impairment

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Single and Repeat Dose Trial in Participants With Hepatic Impairment
GB1211, Placebo - Hepatic Impairment
Phase 1 / Phase 2UnknownGalecto Biotech AB542021-09-092023-05-11
A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
LCZ696 - Hepatic Impairment
Phase 2CompletedNovartis Pharmaceuticals322012-09-012015-08-10

Narrower conditions

Liver Cirrhosis (1)

Broader conditions

Digestive System Diseases (1)  ·  Fibrosis (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

sacubitril and valsartan sodium hydrate drug combination (1)

Sponsors

Galecto Biotech AB (1)  ·  Novartis Pharmaceuticals (1)

Countries

Bulgaria (1)  ·  Germany (1)

Top investigators

Zahariy Krastev, MD (1)

Results publications

PMID 39358661